Short Communication
Austin J Trop Med & Hyg. 2015;1(1): 1005.
Antibacterial Activity of Berberine against Methicillin-Resistant Staphylococcus Aureus Planktonic and Biofilm Cells
Endo EH1*, Dias Filho BP1
1Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Av. Colombo 5790, 87020-900 Maringá-PR, Brazil
*Corresponding author: Endo EH, Departamento de Ciencias Basicas da Saúde, Universidade Estadual de Maringa, Av. Colombo 5790, 87020-900 Maringa-PR, Brazil
Received: December 19, 2014; Accepted: February 17, 2014; Published: February 19, 2015
Abstract
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a pathogenic bacterium which may cause serious infections. Biofilm formation is an important factor involved in difficult eradication of bacteria. Natural products may be an alternative for therapeutic development and berberine has diverse biological effects including antibacterial. In this study, activity of berberine against planktonic and biofilm cells of MRSA were determined. MICs values ranged from 62.5 to 250 μg/ml and MBC values were the same or two fold above the MIC. Biofilms of half of the strains were also inhibited by berberine at concentrations of 125 to 1000 μg/ml. Further studies are necessary; however there is a potential application of berberine in the development of strategies against bacteria.
Keywords: Berberine; Antibacterial; MRSA; Biofilm
Introduction
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a Grampositive bacterium which causes community- and hospital-acquired infections. Biofilm formation is one defense mechanism, since bacteria embedded in biofilms are more difficult to eradicate than planktonic cells. Single-drug treatment for MRSA related infections is becoming less effective and natural products may be an alternative for future antibacterial medicine development [1-3]. Berberine is a plant alkaloid, important in Chinese medicine and characterized by diverse biological activities such as antimicrobial, antihypertensive, anti-inflammatory, anti-oxidant, anti-depressant, anti-cancer, antidiarrheal, cholagouge, hepato protective, and anti-diabetic activities [4,5]. In this short communication we relate activity of berberine against planktonic and biofilm cells of MRSA and MSSA.
Materials and Methods
Strains and growth conditions
Bacterial strains were Staphylococcus aureus ATCC 29213 and 13 clinical isolates, 10 MRSA (methicillin-resistant strains 72,73,74,76,77,78,79,81,83,90) and 3 MSSA (methicillin-sensitive strains 97,170,212). They were maintained in Mueller Hinton Agar (AMH-Difco) at 4°C and cultured in Mueller Hinton Broth (MHBDifco) before each experiment.
Microdilution MIC determination
Antibacterial and antifungal assays were performed by micro dilution method in sterile flat-bottom microplates according to CLSI [6]. Each well contained appropriate test samples, culture medium, and approximately 105 cells/ml for bacteria. Serial two-fold dilutions of berberine were done in a micro dilution plate (96 wells) containing 100 μl of culture medium. Next, the inoculum was added to each well. The microplates were incubated at 37°C during 24h. The MIC was defined as the lowest concentration which resulted in inhibition of visual growth. Minimal Bactericidal Concentrations (MBC) was determined by sub culturing 10 μl of the culture from each negative well and from the positive control.
Biofilm
S. aureus biofilm was formed in a polystyrene 96-well micro titer plates. Assays were done twice in triplicate. 100 μl of a suspension containing 1 x 108 cells/ml TSB medium supplemented with 1% glucose were seeded in wells and incubated at 37°C for 24 h. Well content was discharged, wells were washed with Phosphate Buffered Saline (PBS) and dilutions of berberine ranging from 15.6 to 1000 μg/ ml were added to each well. After incubation at 37°C for 24h, wells were rinsed with PBS. For MTT reduction assay, slight modifications on method utilized by Schillaci et al. [7] were done. 20 μl of MTT solution (5 mg/ml in PBS) was added to each well and plates were incubated at 37°C for 2 h. After staining, MTT solution was removed from each well and 100 μl of DMSO was added to dissolve MTT formazan product. 100 μl of DMSO was transferred to a new plate and optical density was measured at 570 nm using a microplate reading. BIC50 was the concentration enough to inhibit viability of biofilm in 50%.
Results and Discussion
Berberine is a plant alkaloid with historical medicinal use in Chinese medicine; it has demonstrated antimicrobial activity against bacteria, fungi, and viruses, protozoans, helminthes and chlamydia [4]. In this study, MIC values for berberine ranged from 62.5 to 250 μg/ml against MRSA strains, MBC values were the same or two fold above the MIC. To Methicillin-sensitive S. aureus (MSSA) strains 97,170 and 212, berberine MIC values were 125 and 500 μg/ml. Inhibitory concentration for biofilm (BIC50) were 1000 μg/ml for four strains, 500 μg/ml for two strains and 125 μg/ml for just one strain. BIC50 could not be determined to half of all strains because the maximum concentration tested was 1000 μg/ml [Table 1].
S. aureus strains
MIC
MBC
BIC50
ATCC 29213
125
125
-
72
125
250
-
73
125
125
1000
74
125
250
-
76
125
125
-
77
125
125
-
78
250
250
500
79
62.5
125
125
81
125
250
-
83
125
125
1000
90
125
250
1000
97
125
250
-
170
125
250
1000
212
500
1000
500
Table 1: MIC, MBC and BIC50 values for berberine against S. aureus strains.
Our MIC results are according to other authors who showed antibacterial activity of berberine. Yu et al. [8] related MICs of berberine against MRSA between 32 and 128 μg/ml and a synergistic effect when associated with oxacillin. Wang et al. [9] related the effect of berberine on Staphylococcus epidermidis biofilm formation. Wojtyczka et al. [10] showed MICs of berberine chloride against coagulase-negative Staphylococcus between 16 and 512 μg/ml with synergistic effect in combination with linezolid, cefoxitin and erythromycin. Liang et al. [11] showed synergistic effect of berberine in association with fusidic acid against MRSA clinical isolates. However, the mechanism involved in antibacterial action of berberine has not been extensively studied. Possible action would be binding to DNA, which contributes to antimicrobial effect, and binding proteins in biofilm, interrupting its stability and thus enhance the antibacterial activity of antibiotic [12,13].
Conclusion
These results showed antibacterial activity of berberine against planktonic and biofilm cells of MRSA and MSSA. Further studies are necessary to assess synergistic effects of berberine in combination with antibiotics against these strains. However, these data indicated a potential application of berberine in the development of strategies for staphylococcal infections.
References
- Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol. 2007; 45: 1705-1711.
- Zuo GY, Wang GC, Zhao YB, Xu GL, Hao XY, Han J, et al. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin- resistant Staphylococcus aureus (MRSA). J Ethnopharmacol. 2008; 120: 287-290.
- Patel R: Biofilms and antimicrobial resistance. Clin Orthop Relat Res. 2005: 41-47.
- Birdsall TC, Kelly GS. Berberine: Therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev. 1997; 2: 94-100.
- Singh A, Duggal S, Kaur N, Singh J. Berberine: Alkaloid with wide spectrum of pharmacological activities. J Nat Products. 2010; 3: 64-75.
- Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard, 9th edn. M07-A9, CLSI, Wayne, PA. 2012; 32.
- Schillaci D, Arizza V, Dayton T, Camarda L, Stefano VD. In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils. Lett Appl Microbiol. 2008; 47: 433-438.
- Yu NH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food. 2005; 8: 454-461.
- Wang XQ, Yao X, Zhu Z, Tang, TT, Dai K, Sadovskaya I, et al. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int J Antimicrob Agents. 2009; 34: 60-66.
- Wojtyczka RD, Dziedzic A, Kepa M, Kubina R, Dzik AK, Mularz T, et al. Berberine Enhances the Antibacterial Activity of Selected Antibiotics against Coagulase-Negative Staphylococcus Strains in Vitro. Molecules. 2014; 19: 6583-6596.
- Liang RM, Yong XL, Duan YQ, Tan YH, Zeng PZ, Zhou ZY, et al. Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). World J Microbiol Biotechnol. 2014; 30: 2861-2869.
- Chu M, Xiao R, Yin Y, Wang X, Chu Z, Zhang MB, et al. Berberine: A Medicinal Compound for the Treatment of Bacterial Infections. Clin Microbial. 2014; 3: 150.
- Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. PNAS. 2000; 97: 1433-1437.